Nasdaq approves listing of Canary's staked Injective ETF
Nasdaq approves INJC listing, The Defiant reports
Nasdaq has approved the listing of Canary's proposed staked Injective ETF, called INJC, according to The Defiant.
An ETF, or exchange-traded fund, is a fund traded on an exchange that holds an asset or a group of assets. The report describes INJC as a proposed fund linked to Injective.
At least 90% staked and a 1.10% annual sponsor fee
- The fund would stake at least 90% of its INJ holdings.
- The fund would charge a 1.10% annual sponsor fee.
- The fund is identified by the ticker INJC.
No launch date or trading details in the report
The supplied report does not state when INJC would begin trading. It also does not provide other listing details.
Where this report comes from
Newisty Editorial Team covers technology, cryptocurrency, digital products, online platforms, developer tools and the wider digital economy. Our content is researched from official sources, company announcements, public documentation, market data and other primary or reputable sources. Articles are reviewed and edited before publication for clarity, accuracy and useful context.